Episodes featuring TBPN

Browse episodes where TBPN appears as host or guest. View all episodes →

TBPN
Midjourney Medical, AI Talent Wars 2.0, G7 Recap, Jake Paul Joins
TBPN · with Derek Thompson, Renee Haas, David Senra, Jake Paul · Jun 18, 2026 · 4 recommendations

TBPN hosts John Coogan, Jordi Hays, Derek Thompson, Renee Haas, David Senra, and Jake Paul discuss Midjourney's move into medical imaging, AI talent shifts, and self-optimization culture.

TBPN
Snap SPECS, Taste Labs Timeline Turmoil, AI Execs at G7 | Diet TBPN
TBPN · Jun 18, 2026 · 1 recommendation

John Coogan and Jordi Hays join TBPN to discuss Snap's $2,200 AR glasses, the Taste Labs startup debate, and AI export controls at the G7.

TBPN
Snap Specs, Taste, Midjourney Hardware, Lunchtime for AI Leaders
TBPN · with Eric Newcomer, Merrill Lutsky, Carter Reum, Thomas Suarez, Mark Gurman · Jun 17, 2026 · 6 recommendations

TBPN hosts and guests discuss Snap Spectacles, a startup called Taste Labs that improves AI aesthetic output, and how media businesses like Eric Newcomer's stay defensible against AI.

TBPN
SpaceX Takes Off, Cursor's Wild Rise, Snap Bets on AR Glasses | Diet TBPN
TBPN · Jun 17, 2026 · 9 products mentioned

TBPN, John Coogan, and Jordi Hays break down SpaceX's IPO valuation, its $60 billion Cursor acquisition, and Snap's new $2,195 AR glasses.

TBPN
YC Demo Day Lightning Round, New Snap AR Glasses, SpaceX Rips, Threads hits 500M Users
TBPN · with Andrew Lee, Stamatis Floratos, Hugo Frisk, Efrain Torres, Russell Smith, Payton Case, Diana Hu · Jun 16, 2026 · 3 recommendations

The TBPN team hosts YC Demo Day Summer 2026 with seven founders and three YC partners, covering AI agents, defense robotics, medical devices, and space infrastructure startups.

TBPN
Anthropic Drama, Meta Now Tokenminning, Fox's $22B Roku Deal | Diet TBPN
TBPN · Jun 16, 2026 · 8 products mentioned

John Coogan and Jordi Hays from TBPN discuss Anthropic's export control clash with the US government, Meta's shift to disciplined AI spending, and Fox's $22 billion Roku acquisition.

TBPN
America 250 Recap with Bo Nickal, Gavin Baker Joins, Anthropic in Washington, Le Chaton Fat
TBPN · with Bo Nickal, Gavin Baker, Leif Abraham · Jun 15, 2026 · 1 recommendation

TBPN hosts recap UFC Freedom 250 at the White House with fighter Bo Nickal, then cover Anthropic's regulatory troubles, the SpaceX IPO, and how retail investors are changing capital markets.

TBPN
Gavin Baker: SpaceX Might Be the Greatest Company of All Time
TBPN · with Gavin Baker · Jun 15, 2026 · 1 recommendation

Gavin Baker joins TBPN to discuss why SpaceX may be the greatest company ever built, covering AI compute, orbital infrastructure, and retail investor trends.

TBPN
🚀 SpaceX IPO Liftoff | Diet TBPN
TBPN · Jun 13, 2026 · 1 recommendation

John Coogan and Jordi Hays join TBPN to break down the SpaceX IPO, which opened at $150 a share and popped 24%, and what the company's two-decade rise means for founders.

TBPN
SpaceX IPO Gigastream
TBPN · Jun 12, 2026 · 1 recommendation

John Coogan and Jordi Hays discuss SpaceX's IPO at a $2.28 trillion valuation, covering Gwen Shotwell's career, the stock's pricing risk, and lessons for founders and investors.

TBPN
Bezos' Prometheus Raises $12B, America Inc. Moves to Texas, Trucking Rebounds | Diet TBPN
TBPN · Jun 12, 2026 · 10 products mentioned

John Coogan and Jordi Hays from TBPN cover Bezos-backed AI startup Prometheus raising $12B, Texas becoming America's top corporate destination, and trucking's recovery after a four-year slump.

TBPN
Bezos AI Play, Future of Airports, Trucking is Back, CAA Fund
TBPN · with Ariel Cohen, Jeff Dartuk, Matthew Joseph, Adeyemi Ajao, Jeremy Frank · Jun 11, 2026 · 3 recommendations

TBPN hosts and guests cover Jeff Bezos's $12B AI manufacturing bet, a robotics funding surge, trucking's recovery, and shifting capital toward Texas.

TBPN
Cloudflare CEO Predicts AI Agents Will Outnumber Humans 1,000-to-1
TBPN · with Matthew Prince · Jun 10, 2026 · 2 recommendations

Cloudflare CEO Matthew Prince joins TBPN's John Coogan and Jordi Hays to discuss why AI agents need new infrastructure, bot traffic overtaking humans, edge inference, IPO lessons, and why he is hiring more interns.

TBPN
Social Network Sequel Trailer, Fable 5 Sparks Safety Debate, SpaceX IPO Watch | Diet TBPN
TBPN · Jun 10, 2026 · 7 products mentioned

John Coogan and Jordi Hays cover the Social Network sequel trailer, Anthropic's Claude 3.5 safety debate, and what SpaceX's IPO structure means for investors.

TBPN
WWDC Reactions, Claude Fable 5 Debuts, McAfee Eyes ESPN Mega Deal | Diet TBPN
TBPN · Jun 10, 2026 · 6 products mentioned

TBPN reacts to Apple's WWDC 2026 announcements and broader AI news, covering Siri's long-delayed improvement, parental controls, AI model integration, and OpenAI's test-time compute findings.

TBPN
Siri AI, Fable Launch, China Wakes Up, Rivian CEO Joins, IPO Filings, Learn to Weld?
TBPN · with Nick Fleer, Chris Meresi, Alex Heath · Jun 09, 2026 · 2 recommendations

TBPN, Nick Fleer, Chris Meresi, and Alex Heath discuss Apple's revamped Siri, Rivian's R2 launch, and China's $295B AI fund announced on June 9, 2026.

TBPN
WWDC Kicks Off, Jobs Up, Tech Down, VC Horror Stories Go Viral | Diet TBPN
TBPN · Jun 09, 2026 · 1 recommendation

The TBPN hosts cover Apple's WWDC AI announcements, May jobs data showing 172,000 new roles, a NASDAQ drop of 4.2%, and viral VC horror stories.

TBPN
WWDC, Jobs Up Stocks Down, VC Horror Stories, Cars and Planes
TBPN · Jun 08, 2026 · 1 product mentioned

The TBPN hosts cover Apple's WWDC AI announcements, a solid US jobs report, market moves, and a viral thread of VC horror stories from founders.

TBPN
Palantir CEO Alex Karp on Tokenmaxxing & Taste
TBPN · with Alex Karp · Jun 04, 2026 · 1 product mentioned

Palantir CEO Alex Karp joins TBPN to argue that taste and judgment matter more than raw AI power, and explains how enterprises misuse and misunderstand AI tools.

TBPN
Palantir's AIPCon 10, Ramp Hits $44B, 60 Minutes Eyes Rogan | Diet TBPN
TBPN · Jun 04, 2026 · 8 products mentioned

TBPN covers nucleic acid synthesis regulation, Ramp's $44B valuation, and a biotech revival driven by AI-first founders.